Spring direct naar de hoofdnavigatie of de inhoud

Jennifer Ebner von Eschenbach

Patent attorney

“Investing that little extra time and effort in IP at the right moment makes your technology go further.”
Home / Experts / Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach
T +49 89 890 636 936

Jennifer Ebner von Eschenbach

  • Chemistry
  • Life Sciences
  • European Patent Attorney
  • Senior Associate

Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

More information about Jennifer

Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients.

Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

Working experience

  • Patent Attorney, V.O. (2008-present)
  • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
  • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)

Education

  • PhD in Chemistry, University of Melbourne (1988)
  • MSc in Chemistry, University of Melbourne (1984, with honours)

Publications

  • •Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
  • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
  • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
  • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988

Languages

  • German
  • English

See also

Also see these experts

Bettina Hermann

Bettina Hermann

  • European Patent Attorney
  • German Patent Attorney
  • European and German Trademark and Design Attorney
  • Partner
Jetze Beeksma

Jetze Beeksma

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
More experts

News

Brexit

The impact of Brexit on IP rights

The United Kingdom (UK) is expected to leave the European Union on 29 March 2019, with or without a deal. The British Parliament has expressly stated that the existing IP rights that have been established within the EU context will be guaranteed in either case. Below you will find a brief overview of the impact […]Continue reading

Supplier must warn of potential patent infringement in another country

Imagine that you sell a product that does not fall under the Netherlands’ patent protection to a customer, but your customer then exports the product to Germany where it is protected by a patent. How does this affect your liability?Continue reading

Organ Assist

More organs available thanks to active Organ Assist’s active IP policy

The number of organs transplants in Dutch hospitals is greatly on the rise: with 15% in 2018. This increase is partly the result of the organ perfusion machine developed by Groningen company Organ Assist.Continue reading

More news

Events

NCCC Conference 2019

Hotel NH Noordwijk Conference Centre Leeuwenhorst, Langelaan, Noordwijkerhout

The 20th Netherlands Catalysis and Chemistry Conference will take place March 4-6, 2019 in Noordwijkerhout, The Netherlands. More about this event

Idea, IP & Innovation (3i-) Event

High Tech Campus Eindhoven, High Tech Campus, Eindhoven

On Tuesday 18 April TW.nl organizes the second edition of the 3i-Event. During this inspiring afternoon about Ideas, Intellectual property and Innovation on the Hightech Campus in Eindhoven, R&D professionals, startups and SME entrepreneurs will learn how to set up a successful IP strategy for their companies. More about this event

Knowledge for Growth 2019

Gent ICC, Gent, België

Don’t miss the 2019 edition on 9 May  and capture the attention of 1,200 high-level life sciences actors from about 550 companies & organisations! The cream of the European life sciences community will be attending the 15th edition of flanders.bio’s annual knowledge for growth business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. More about this event

More events